Síndrome de Sjögren (SS)

Referencias:

- https://doi.org/10.1016/j.autrev.2009.11.004
- Mavragani CP, Moutsopoulos HM. Sjögren's syndrome. Annu Rev Pathol. 2014;9:273-285. doi:10.1146/annurev-pathol-012513-104728
- Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new cbrnical and therapeutic concepts. Ann Rheum Dis. 2005;64(3):347-354. doi:10.1136/ard.2004.025676
- Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG. A comprehensive review of autoantibodies in primary Sjögren's syndrome: cbrnical phenotypes and regulatory mechanisms. J Autoimmun. 2014;51:67-74. doi:10.1016/j.jaut.2013.11.001
- https://resident360.nejm.org/cbrnical-pearls/primary-sjogren-s-syndrome
- https://creakyjoints.org/news/sjogrens-syndrome-heart-disease-brnk/
- Nocturne, G., Mariette, X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat Rev Rheumatol 9, 544-556 (2013).
- ALBA, Rafael, et al. Enfermedades Inflamatorias reumatológicas. 1ra edición 2016, pp.397-419
- Kroese, Frans G. M. and Hendrika Bootsma. "Biomarkers: New biomarker for Sjögren's syndrome-time to treat patients." Nature Reviews Rheumatology 9 (2013): 570-572
- https://www.sjogrens.org/understanding-sjogrens
- Shiboski, C., et al., 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome. ARTHRITIS & RHEUMATOLOGY Vol. 69, No. 1, January 2017, pp 35-45
- Mendez-Rayo, T. et al., Interpretación de los autoanticuerpos en enfermedades reumatológicas. Revista Colombiana de Reumatología, Volume 25, Issue 2, April-June 2018, Pages 112-125